A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early e...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7ee595d7e5914568a24a492c5f3d9bb7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7ee595d7e5914568a24a492c5f3d9bb72021-11-25T07:56:43ZA Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis2639-802810.1097/CCE.0000000000000550https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb72021-10-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000550https://doaj.org/toc/2639-8028OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early enteral dextrose infusion on systemic inflammation and glucose metabolism in critically ill septic patients. DESIGN:. Single-center, double-blind, placebo-controlled randomized pilot clinical trial (NCT03454087). SETTING:. Tertiary-care medical center in Pittsburgh, PA. PATIENTS:. Critically ill adult patients within 48 hours of sepsis diagnosis and with established enteral access. INTERVENTIONS:. Participants were randomized 1:1 to receive a continuous water (placebo) or enteral dextrose infusion (50% dextrose; 0.5 g/mL) at 10 mL per hour for 24 hours. MEASUREMENTS AND MAIN RESULTS:. We randomized 58 participants between June 2018 and January 2020 (placebo: n = 29, dextrose: n = 29). Protocol adherence was high with similar duration of study infusion in the placebo (median duration, 24 hr [interquartile range, 20.9–24 hr]) and dextrose (23.9 hr [23–24 hr]) groups (p = 0.59). The primary outcome of circulating interleukin-6 at end-infusion did not differ between the dextrose (median, 32 pg/mL [19–79 pg/mL]) and placebo groups (24 pg/mL [9–59 pg/mL]; p = 0.13) with similar results in other measures of the systemic host immune response. Enteral dextrose increased circulating glucose-dependent insulinotropic peptide (76% increase; 95% CI [35–119]; p < 0.01) and insulin (53% [17–88]; p < 0.01) compared with placebo consistent with preclinical studies, but also increased blood glucose during the 24-hour infusion period (153 mg/dL [119–223] vs 116 mg/dL [91–140]; p < 0.01). Occurrence of emesis, ICU and hospital length of stay, and 30-day mortality did not differ between the placebo and enteral dextrose groups. CONCLUSIONS:. Early infusion of low-level enteral dextrose in critically ill septic patients increased circulating levels of insulin and the incretin hormone glucose-dependent insulinotropic peptide without decreasing systemic inflammation.Faraaz Ali Shah, MD, MPHGeorgios D. Kitsios, MD, PhDSachin Yende, MD, MSDaniel G. Dunlap, MDDenise Scholl, CRCByron Chuan, MSNameer Al-Yousif, MDYingze Zhang, PhDSeyed Mehdi Nouraie, MD, PhDAlison Morris, MD, MSDavid T. Huang, MD, MPHChristopher P. O’Donnell, PhDBryan J. McVerry, MDWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 10, p e550 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 |
spellingShingle |
Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Faraaz Ali Shah, MD, MPH Georgios D. Kitsios, MD, PhD Sachin Yende, MD, MS Daniel G. Dunlap, MD Denise Scholl, CRC Byron Chuan, MS Nameer Al-Yousif, MD Yingze Zhang, PhD Seyed Mehdi Nouraie, MD, PhD Alison Morris, MD, MS David T. Huang, MD, MPH Christopher P. O’Donnell, PhD Bryan J. McVerry, MD A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
description |
OBJECTIVES:. Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early enteral dextrose infusion on systemic inflammation and glucose metabolism in critically ill septic patients.
DESIGN:. Single-center, double-blind, placebo-controlled randomized pilot clinical trial (NCT03454087).
SETTING:. Tertiary-care medical center in Pittsburgh, PA.
PATIENTS:. Critically ill adult patients within 48 hours of sepsis diagnosis and with established enteral access.
INTERVENTIONS:. Participants were randomized 1:1 to receive a continuous water (placebo) or enteral dextrose infusion (50% dextrose; 0.5 g/mL) at 10 mL per hour for 24 hours.
MEASUREMENTS AND MAIN RESULTS:. We randomized 58 participants between June 2018 and January 2020 (placebo: n = 29, dextrose: n = 29). Protocol adherence was high with similar duration of study infusion in the placebo (median duration, 24 hr [interquartile range, 20.9–24 hr]) and dextrose (23.9 hr [23–24 hr]) groups (p = 0.59). The primary outcome of circulating interleukin-6 at end-infusion did not differ between the dextrose (median, 32 pg/mL [19–79 pg/mL]) and placebo groups (24 pg/mL [9–59 pg/mL]; p = 0.13) with similar results in other measures of the systemic host immune response. Enteral dextrose increased circulating glucose-dependent insulinotropic peptide (76% increase; 95% CI [35–119]; p < 0.01) and insulin (53% [17–88]; p < 0.01) compared with placebo consistent with preclinical studies, but also increased blood glucose during the 24-hour infusion period (153 mg/dL [119–223] vs 116 mg/dL [91–140]; p < 0.01). Occurrence of emesis, ICU and hospital length of stay, and 30-day mortality did not differ between the placebo and enteral dextrose groups.
CONCLUSIONS:. Early infusion of low-level enteral dextrose in critically ill septic patients increased circulating levels of insulin and the incretin hormone glucose-dependent insulinotropic peptide without decreasing systemic inflammation. |
format |
article |
author |
Faraaz Ali Shah, MD, MPH Georgios D. Kitsios, MD, PhD Sachin Yende, MD, MS Daniel G. Dunlap, MD Denise Scholl, CRC Byron Chuan, MS Nameer Al-Yousif, MD Yingze Zhang, PhD Seyed Mehdi Nouraie, MD, PhD Alison Morris, MD, MS David T. Huang, MD, MPH Christopher P. O’Donnell, PhD Bryan J. McVerry, MD |
author_facet |
Faraaz Ali Shah, MD, MPH Georgios D. Kitsios, MD, PhD Sachin Yende, MD, MS Daniel G. Dunlap, MD Denise Scholl, CRC Byron Chuan, MS Nameer Al-Yousif, MD Yingze Zhang, PhD Seyed Mehdi Nouraie, MD, PhD Alison Morris, MD, MS David T. Huang, MD, MPH Christopher P. O’Donnell, PhD Bryan J. McVerry, MD |
author_sort |
Faraaz Ali Shah, MD, MPH |
title |
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
title_short |
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
title_full |
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
title_fullStr |
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
title_full_unstemmed |
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis |
title_sort |
pilot double-blind placebo-controlled randomized clinical trial to investigate the effects of early enteral nutrients in sepsis |
publisher |
Wolters Kluwer |
publishDate |
2021 |
url |
https://doaj.org/article/7ee595d7e5914568a24a492c5f3d9bb7 |
work_keys_str_mv |
AT faraazalishahmdmph apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT georgiosdkitsiosmdphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT sachinyendemdms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT danielgdunlapmd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT deniseschollcrc apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT byronchuanms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT nameeralyousifmd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT yingzezhangphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT seyedmehdinouraiemdphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT alisonmorrismdms apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT davidthuangmdmph apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT christopherpodonnellphd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT bryanjmcverrymd apilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT faraazalishahmdmph pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT georgiosdkitsiosmdphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT sachinyendemdms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT danielgdunlapmd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT deniseschollcrc pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT byronchuanms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT nameeralyousifmd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT yingzezhangphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT seyedmehdinouraiemdphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT alisonmorrismdms pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT davidthuangmdmph pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT christopherpodonnellphd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis AT bryanjmcverrymd pilotdoubleblindplacebocontrolledrandomizedclinicaltrialtoinvestigatetheeffectsofearlyenteralnutrientsinsepsis |
_version_ |
1718413628836675584 |